Nutritional status and symptom burden in advanced non-small cell lung cancer: results of the dietetic assessment and intervention in lung cancer (DAIL) trial.
Iain PhillipsLindsey AllanAdele HugNaomi WestranClaudia HeinemannMadeleine HewishAjay MehtaHelen SaxbyVeni EzhilPublished in: BMJ supportive & palliative care (2021)
A large proportion of patients with NSCLC have a high symptom burden and are at risk of malnutrition prior to starting SACT and would benefit from dietetic review. It is imperative that oncologists and healthcare professionals discuss weight loss history and symptoms with lung cancer patients to correct nutritional deficiencies and resolve symptoms prior to starting treatment.
Keyphrases
- advanced non small cell lung cancer
- weight loss
- epidermal growth factor receptor
- randomized controlled trial
- bariatric surgery
- clinical trial
- small cell lung cancer
- study protocol
- sleep quality
- risk factors
- patient reported
- roux en y gastric bypass
- phase iii
- gastric bypass
- replacement therapy
- obese patients
- insulin resistance
- smoking cessation
- weight gain